Skip to main content
. Author manuscript; available in PMC: 2023 Oct 17.
Published in final edited form as: Semin Fetal Neonatal Med. 2020 Oct 23;25(4):101146. doi: 10.1016/j.siny.2020.101146

Fig. 10.

Fig. 10.

Transcriptome analysis of fetal blood using whole genome DASL® assay according to the presence or absence of fetal inflammatory response syndrome (FIRS) type II that is associated with maternal anti-fetal rejection. A clustered heat map based on the top 200 differentially expressed genes displays two main clusters: one dominated by samples of the fetal inflammatory response associated with maternal anti-fetal rejection group (FIRS II) (left) and one dominated by samples in the control group (right). (Reproduced with permission from Lee J, Romero R, Chaiworapongsa T et al. Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response. Am J Reprod Immunol 70:265–84, 2013.).